PTPRF and Huntington disease: Decreased expression of PTPRF has been observed in induced pluripotent stem cells (iPSCs) obtained from Huntington’s disease (HD) patients, which could have a role in some pathological features of this diseases, such as neural dysfunction and cell death (The HD iPSC Consortium, 2012).